Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
1.630
+0.030 (1.87%)
Dec 31, 2025, 4:00 PM EST - Market closed
Codexis Revenue
Codexis had revenue of $8.60M in the quarter ending September 30, 2025, a decrease of -32.98%. This brings the company's revenue in the last twelve months to $52.93M, down -17.87% year-over-year. In the year 2024, Codexis had annual revenue of $59.35M, down -15.39%.
Revenue (ttm)
$52.93M
Revenue Growth
-17.87%
P/S Ratio
2.61
Revenue / Employee
$281,553
Employees
188
Market Cap
147.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 59.35M | -10.80M | -15.39% |
| Dec 31, 2023 | 70.14M | -68.45M | -49.39% |
| Dec 31, 2022 | 138.59M | 33.84M | 32.30% |
| Dec 31, 2021 | 104.75M | 35.70M | 51.69% |
| Dec 31, 2020 | 69.06M | 598.00K | 0.87% |
| Dec 31, 2019 | 68.46M | 7.86M | 12.98% |
| Dec 31, 2018 | 60.59M | 10.57M | 21.13% |
| Dec 31, 2017 | 50.02M | 1.19M | 2.43% |
| Dec 31, 2016 | 48.84M | 7.03M | 16.82% |
| Dec 31, 2015 | 41.80M | 6.50M | 18.40% |
| Dec 31, 2014 | 35.31M | 3.39M | 10.60% |
| Dec 31, 2013 | 31.92M | -56.38M | -63.85% |
| Dec 31, 2012 | 88.30M | -35.57M | -28.71% |
| Dec 31, 2011 | 123.87M | 16.76M | 15.65% |
| Dec 31, 2010 | 107.10M | 24.20M | 29.18% |
| Dec 31, 2009 | 82.91M | 32.43M | 64.25% |
| Dec 31, 2008 | 50.48M | 25.15M | 99.26% |
| Dec 31, 2007 | 25.33M | 13.21M | 108.90% |
| Dec 31, 2006 | 12.13M | 343.00K | 2.91% |
| Dec 31, 2005 | 11.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CDXS News
- 7 weeks ago - Codexis Announces Signing of Lease for GMP Manufacturing Facility - GlobeNewsWire
- 7 weeks ago - Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing - PRNewsWire
- 2 months ago - Codexis to Report Third Quarter 2025 Financial Results on November 6 - GlobeNewsWire
- 4 months ago - Codexis to Participate in Cantor Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Codexis Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Codexis to Report Second Quarter 2025 Financial Results on August 13 - GlobeNewsWire